-
NEWS
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other DiseasesLearn MoreCollaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J., July 25, 2024 /PRNewswire/ -- BD (Becton, Dickinson and...
-
NEWS
BD Board Declares DividendLearn MoreThe Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common...
-
BLOG
Together We AdvanceWe are proud to share a report of impact and progress made toward the goals and commitments we set for 2030+ to advance the health of our company, planet, communities and people.Learn More